• Adabor, E.S., 2021. A statistical analysis of antigenic similarity among influenza A (H3N2) viruses. Heliyon 7, e08384.

  • Anderson, C.S., McCall, P.R., Stern, H.A., Yang, H., Topham, D.J., 2018. Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation. BMC Bioinformatics 19, 1-11.

  • Archetti, I., Horsfall, F.L.J., 1950. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J. Exp. Med. 92, 441-462.

  • Bouckaert, R., Vaughan, T.G., Barido-Sottani, J., Duchêne, S., Fourment, M., Gavryushkina, A., Heled, J., Jones, G., Kühnert, D., De Maio, N., Matschiner, M., Mendes, F.K., Müller, N.F., Ogilvie, H.A., Du Plessis, L., Popinga, A., Rambaut, A., Rasmussen, D., Siveroni, I., Suchard, M.A., Wu, C.H., Xie, D., Zhang, C., Stadler, T., Drummond, A.J., 2019. BEAST 2.5:An advanced software platform for Bayesian evolutionary analysis. PLoS Comput. Biol. 15, 1-28.

  • Caton, A.J., Brownlee, G.G., Yewdell, J.W., Gerhard, W., 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31, 417-427.

  • Chung, J.R., Rolfes, M.A., Flannery, B., Prasad, P., O'Halloran, A., Garg, S., Fry, A.M., Singleton, J.A., Patel, M., Reed, C., Kim, S.S., Martin, E.T., Monto, A.S., Jackson, M.L., Jackson, L.A., McLean, H.Q., Belongia, E.A., King, J.P., Zimmerman, R.K., Nowalk, M.P., Balasubramani, G.K., Bear, T.M., Hickey, R., Raviotta, J.M., Suyama, J., Weissman, A.J., Williams, J. V., Gaglani, M., Raiyani, C., Smith, M., Murthy, K., Clipper, L., Reis, M., Rao, A., Walker, K., Volz, M., Mutnal, M., Cummings, C.N., Yousey-Hindes, K., McMullen, C., Chai, S.J., Anderson, E.J., Monroe, M.L., Risk, I., Herlihy, R., Kim, S., Spina, N., Billing, L., Schaffner, W., Keipp Talbot, H., Thomas, A., McMahon, M., 2020. Effects of Influenza Vaccination in the United States during the 2018-2019 Influenza Season. Clin. Infect. Dis. 71, E368-E376.

  • Du, X., Dong, L., Lan, Y., Peng, Y., Wu, A., Zhang, Y., Huang, W., Wang, D., Wang, M., Guo, Y., Shu, Y., Jiang, T., 2012. Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation. Nat. Commun. 3, 709.

  • Enright, A.J., Van Dongen, S., Ouzounis, C.A., 2002. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 30, 1575-1584.

  • Frost, W.H., 1920. Statistics of Influenza Morbidity:With Special Reference to Certain Factors in Case Incidence and Case Fatality. Public Health Rep. 35, 584-597.

  • Harvey, W.T., Benton, D.J., Gregory, V., Hall, J.P.J., Daniels, R.S., Bedford, T., Haydon, D.T., Hay, A.J., McCauley, J.W., Reeve, R., 2016. Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses. PLoS Pathog. 12, 1-23.

  • Hensley, S.E., 2014. ScienceDirect Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr. Opin. Virol. 8, 85-89.

  • Huson, D.H., Richter, D.C., Rausch, C., Dezulian, T., Franz, M., Rupp, R., 2007. Dendroscope:An interactive viewer for large phylogenetic trees. BMC Bioinformatics 8, 460.

  • Kilbourne, E.D., 2006. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 12, 9-14.

  • Klingen, T.R., Reimering, S., Guzmán, C.A., McHardy, A.C., 2018. In Silico Vaccine Strain Prediction for Human Influenza Viruses. Trends Microbiol. https://doi.org/10.1016/j.tim.2017.09.001

  • Lee, E.K., Tian, H., Nakaya, H.I., 2020. Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks. Hum. Vaccines Immunother. 16, 2690-2708.

  • Li, L., Chang, D., Han, L., Zhang, X., Zaia, J., Wan, X.F., 2020. Multi-task learning sparse group lasso:A method for quantifying antigenicity of influenza A(H1N1) virus using mutations and variations in glycosylation of Hemagglutinin. BMC Bioinformatics 21, 1-22.

  • Li, W., Godzik, A., 2006. Cd-hit:a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22, 1658-1659.

  • Li, Y., Myers, J.L., Bostick, D.L., Sullivan, C.B., Madara, J., Linderman, S.L., Liu, Q., Carter, D.M., Wrammert, J., Esposito, S., Principi, N., Plotkin, J.B., Ross, T.M., Ahmed, R., Wilson, P.C., Hensley, S.E., 2013. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J. Exp. Med. 210, 1493-1500.

  • Liao, Y.-C., Lee, M.-S., Ko, C.-Y., Hsiung, C. a, 2008. Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics 24, 505-12.

  • Liu, M., Zhao, X., Hua, S., Du, X., Peng, Y., Li, X., Lan, Y., Wang, D., Wu, A., Shu, Y., Jiang, T., 2015. Antigenic Patterns and Evolution of the Human Influenza A (H1N1) Virus. Sci. Rep. 5, 1-8.

  • Liu, S.T.H., Behzadi, M.A., Sun, W., Freyn, A.W., Liu, W.C., Broecker, F., Albrecht, R.A., Bouvier, N.M., Simon, V., Nachbagauer, R., Krammer, F., Palese, P., 2018. Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance. J. Clin. Invest. 128, 4992-4996.

  • Monto, A.S., 2018. Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years :An Expanding Framework for Influenza Detection, Prevention and Control. Influenza Other Respi. Viruses 12, 10-12.

  • Peng, Y., Wang, D., Wang, J., Li, K., Tan, Z., Shu, Y., Jiang, T., 2017. A universal computational model for predicting antigenic variants of influenza A virus based on conserved antigenic structures. Sci. Rep. 7, 1-7.

  • Price, M.N., Dehal, P.S., Arkin, A.P., 2009. Fasttree:Computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 26, 1641-1650.

  • Qiu, J., Tian, X., Liu, Y., Lu, T., Wang, H., Shi, Z., Lu, S., Xu, D., Qiu, T., 2022. Univ-flu:A structure-based model of influenza A virus hemagglutinin for universal antigenic prediction. Comput. Struct. Biotechnol. J. 20, 4656-4666.

  • Rolfes, M.A., Flannery, B., Chung, J.R., O'Halloran, A., Garg, S., Belongia, E.A., Gaglani, M., Zimmerman, R.K., Jackson, M.L., Monto, A.S., Alden, N.B., Anderson, E., Bennett, N.M., Billing, L., Eckel, S., Kirley, P.D., Lynfield, R., Monroe, M.L., Spencer, M., Spina, N., Talbot, H.K., Thomas, A., Torres, S.M., Yousey-Hindes, K., Singleton, J.A., Patel, M., Reed, C., Fry, A.M., McLean, H.Q., King, J.P., Nowalk, M.P., Balasubramani, G.K., Bear, T.M., Hickey, R., Williams, J. V., Reis, E.C., Moehling, K.K., Eng, H., Jackson, L.A., Smith, Michael, Raiyani, C., Clipper, L., Murthy, K., Chen, W., Reis, M., Petrie, J.G., Malosh, R.E., McSpadden, E.J., Segaloff, H.E., Cheng, C.K., Truscon, R., Johnson, E., Lamerato, L.E., Rosenblum, B., Ford, S., Johnson, M., Raviotta, J.M., Sax, T., Steele, J., Susick, M., Chabra, R., Garofolo, E., Iozzi, P., Kevish, B., Middleton, D.B., Urbanski, L., Ponder, T., Crumbaker, T., Iosefo, I., Sleeth, P., Gandy, V., Bounds, K., Kylberg, M., Rao, A., Fader, R., Walker, K., Volz, M., Ray, J., Price, D., Thomas, J., Wehbe-Janek, H., Beeram, M., Boyd, J., Walkowiak, J., Probe, R., Couchman, G., Motakef, S., Arroliga, A., Kaniclides, A., Bouldin, E., Baker, C., Berke, K., Smith, Mackenzie, Rajesh, N., Alleman, E., Bauer, S., Groesbeck, M., Brundidge, K., Hafeez, N., Jackson, J., Anastasia, I., Kadoo, G., Petnic, S., Ryan, A., Maslar, A., Meek, J., Chen, R., Stephens, S., Thomas, S., Segler, S., Openo, K., Fawcett, E., Farley, M., Martin, A., Ryan, P., Sunkel, R., Lutich, T., Perlmutter, R., Grace, B., Blood, T., Zerrlaut, C., McMahon, M., Strain, A., Christensen, J., Angeles, K., Butler, L., Khanlian, S., Mansmann, R., McMullen, C., Pradhan, E., Manzi, K., Felsen, C., Gaitan, M., Long, K., Fisher, N., Hawley, E., O'Shaughnessy, R., Scott, M., Crawford, C., Schaffner, W., Markus, T., Leib, K., Dyer, K., Santibanez, T., Zhai, Y., Lu, P., Srivastav, A., Hung, M.C., 2019. Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season. Clin. Infect. Dis. 69, 1845-1853.

  • Sandbulte, M.R., Westgeest, K.B., Gao, J., Xu, X., Klimov, A.I., Russell, C. a, Burke, D.F., Smith, D.J., Fouchier, R. a M., Eichelberger, M.C., 2011. Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 108, 20748-53.

  • Shu, Y., Mccauley, J., 2017. GISAID :Global initiative on sharing all influenza data-from vision to reality. Eurosurveillance 22, 2-4. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494

  • Smith, G.J.D., Bahl, J., Vijaykrishna, D., Zhang, J., Poon, L.L.M., Chen, H., Webster, R.G., Peiris, J.S.M., Guan, Y., 2009. Dating the emergence of pandemic influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 106, 11709-11712.

  • Tenforde, M.W., Kondor, R.J.G., Chung, J.R., Zimmerman, R.K., Nowalk, M.P., Jackson, M.L., Jackson, L.A., Monto, A.S., Martin, E.T., Belongia, E.A., McLean, H.Q., Gaglani, M., Rao, A., Kim, S.S., Stark, T.J., Barnes, J.R., Wentworth, D.E., Patel, M.M., Flannery, B., 2021. Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020. Clin. Infect. Dis. 73, e4244-e4250.

  • Thompson, J.D., Gibson, T.J., Higgins, D.G., 2002. Multiple Sequence Alignment Using ClustalW and ClustalX, in:Current Protocols in Bioinformatics. John Wiley & Sons, Inc.

  • World Health Organization, 2022. Recommended composition of influenza virus vaccines for use in the 2023 southern hemisphere influenza season. Wkly. Epidemiol. Rec 43, 537-566.

  • World Health Organization, 2021. Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season. Wkly. Epidemiol. Rec. 11, 77-88.

  • World Health Organization, 2020. Recommended composition of influenza virus vaccines for use in the 2020-2021 northern hemisphere influenza season. Wkly. Epidemiol. Rec. 12, 105-116.

  • World Health Organization, 2019a. Recommended composition of influenza virus vaccines for use in the 2019-2020 northern hemisphere influenza season 12, 141-150.

  • World Health Organization, 2019b. Recommended composition of influenza virus vaccines for use in the 2020 southern hemisphere influenza season September. Wkly. Epidemiol. Rec. 42, 473-484.

  • World Health Organization, 2017. Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season. Wkly. Epidemiol. Rec. 42, 625-633.

  • World Health Organization, 2010. Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly. Epidemiol. Rec. 85, 81-92.

  • World Health Organization, 1978. Influenza. Wkly. Epidemiol. Rec. 53, 21-24.

  • Xia, Y.L., Li, W., Li, Y., Ji, X.L., Fu, Y.X., Liu, S.Q., 2021. A Deep Learning Approach for Predicting Antigenic Variation of Influenza A H3N2. Comput. Math. Methods Med. 2021, 1-10.

  • Xu, R., Ekiert, D.C., Krause, J.C., Hai, R., Crowe, J.E., Wilson, I.A., 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (80-.). 328, 357-360.

  • Yin, R., Thwin, N.N., Zhuang, P., Lin, Z., Kwoh, C.K., 2019. IAV-CNN:A 2D Convolutional Neural Network Model to Predict Antigenic Variants of Influenza A Virus. IEEE/ACM Trans. Comput. Biol. Bioinforma. 19, 3497-3506.

  • Yin, R., Tran, V.H., Zhou, X., Zheng, J., Kwoh, C.K., 2018. Predicting antigenic variants of H1N1 influenza virus based on epidemics and pandemics using a stacking model. PLoS One 13, 1-16.